Loading...
•
Jun 30, 2020
Orthofix Q2 2020 Earnings Report
Reported a decrease in net sales and a loss per share due to the impact of COVID-19, but saw sequential revenue rebound in May and June and record motion preservation sales in the U.S.
Key Takeaways
Orthofix Medical Inc. reported a 37% decrease in net sales to $73.1 million for the second quarter of 2020, with a net loss of ($0.96) per share. However, the company saw sequential revenue rebound in May and June and record motion preservation sales in the U.S.
Net sales decreased by 37% compared to the prior year, totaling $73.1 million.
Earnings per share (EPS) was ($0.96), and adjusted EPS was ($0.59).
Motion Preservation sales in the U.S. reached a record $3.6 million, a 24% sequential increase.
The company is optimistic about continued recovery and is investing in strategic initiatives.
Orthofix
Orthofix
Orthofix Revenue by Segment
Revenue by Segment
Bone Growth Therapies Revenue
CapyFin.comSpinal Implants, Biologics and Enabling Technologies Revenue
CapyFin.comGlobal Spine Revenue
CapyFin.com Forward Guidance
Due to the uncertainty of the COVID-19 pandemic, Orthofix is not providing quantitative guidance for the third quarter of 2020 or for the full year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income